NFKBIA and colitis: Together with vitamin D and its proposed anti-inflammatory properties, vitamin D may reduce colitis by regulating COX-2, TNF-α, NF-κB through IkBa expression, RXR signaling, and vitamin D-activating enzymes CYP24A1 and CYP27B1.